Phillip G. Pymm

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Nanobodies against Plasmodium adhesins that block receptor engagement and malaria parasite invasion.

Nanobodies against Plasmodium adhesins that block receptor engagement and malaria parasite invasion.

Journal: The Biochemical journal

Published: May 18, 2026

Alpseq: an open-source workflow to turbocharge nanobody discovery with high-throughput sequencing.

Alpseq: an open-source workflow to turbocharge nanobody discovery with high-throughput sequencing.

Journal: mAbs

Published: February 03, 2026

Crystal structure and nanobodies against domain 3 of the malaria parasite fusogen Plasmodium falciparum HAP2.

Crystal structure and nanobodies against domain 3 of the malaria parasite fusogen Plasmodium falciparum HAP2.

Journal: The Biochemical journal

Published: November 25, 2025

Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses.

Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses.

Journal: EBioMedicine

Published: June 11, 2025

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses.

A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses.

Journal: NPJ vaccines

Published: May 26, 2025

Stabilized designs of the malaria adhesin protein PvRBP2b for use as a potential diagnostic for Plasmodium vivax.

Stabilized designs of the malaria adhesin protein PvRBP2b for use as a potential diagnostic for Plasmodium vivax.

Journal: The Journal of biological chemistry

Published: January 11, 2025

The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6/32.

The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6/32.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: June 07, 2024

Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection.

Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection.

Journal: Journal of virology

Published: May 06, 2024

Author Correction: A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts.

Author Correction: A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts.

Journal: Nature cell biology

Published: December 18, 2023

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants.

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants.

Journal: Medical microbiology and immunology

Published: April 22, 2023

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Journal: Frontiers in immunology

Published: December 13, 2022

A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts.

A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts.

Journal: Nature cell biology

Published: May 24, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026